Brain

Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia

–   New Evidence Indicates ATH434 can Function as an Iron Chaperone to Redistribute Iron   – MELBOURNE, Australia and SAN FRANCISCO,…

3 months ago

Solstice Pacific Residential Treatment Center Awarded Behavioral Health Care and Human Services Accreditation From the Joint Commission

Treatment of TBI and Mental Health Disorders in a High Service, Private Oceanside SettingSAN CLEMENTE, CA / ACCESSWIRE / April…

3 months ago

CompendiRx Unveils Innovative Approach to Long COVID: Empowering Patients Worldwide

NASHVILLE, TN / ACCESSWIRE / April 26, 2024 / The latest data from the US Census Bureau reflects alarming statistics…

3 months ago

Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)

April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready…

3 months ago

Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management

Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 26, 2024…

3 months ago

Neurosurgery Customer from Germany Orders Nexstim NBS System 5

Press release, Helsinki, 26 April 2024 at 3 PM (EEST) Neurosurgery Customer from Germany Orders Nexstim NBS System 5 Nexstim…

3 months ago

Nexstim Plc Business Update Q1 2024

Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim”…

3 months ago

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also…

3 months ago

NUTRACEUTICAL INNOVATOR STEMREGEN® BOLSTERS LEADERSHIP TEAM WITH INDUSTRY INSIDERS FOCUSED ON EXPANSION GOALS

AUSTIN, Texas, April 25, 2024 /PRNewswire/ -- STEMREGEN®, the pioneer in stem cell science creating the most powerful supplements that…

3 months ago